Zihong Chen

2PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 10, 2025
Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors.

Zihong Chen, Gang Chen, Yuxiang Ma

|Apr 10, 2024
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis.

Yaxiong Zhang, Zihong Chen, Yu Liu

Pageof 1

Frequent Collaborators

1 joint publications

Xue Hou

1 joint publications

Li Zhang

1 joint publications

Jing Li

1 joint publications

Gang Chen